Carl Spickett has extensive experience in translational medicine, currently serving as the Director of Translational Medicine and previously as the Associate Director at Creyon Bio. Prior roles include Lead Scientist, Senior Research Scientist, and Research Scientist at Deep Genomics. Carl Spickett also held postdoctoral positions at the University of Cambridge, specifically in the Department of Medical Genetics and the Department of Pathology. Educationally, Carl Spickett earned a PhD in Molecular Biology from King's College London and a Master of Research in Biochemical Research from Imperial College London.